PanGen Biotech Inc. (KOSDAQ:222110)
South Korea · Delayed Price · Currency is KRW 4,565.00
0.00 (0.00%)
At close: Jul 20, 2026
PanGen Biotech Market Cap
PanGen Biotech has a market cap or net worth of 62.1 billion as of July 21, 2026. Its market cap has decreased by -24.93% in one year.
Market Cap
62.10B
Enterprise Value
50.40B
Revenue
13.71B
Ranking
n/a
PE Ratio
31.58
Stock Price
4,565.00
ChartMarket Cap Chart
Since March 11, 2016, PanGen Biotech's market cap has decreased from 171.29B to 62.10B, a decrease of -63.75%. That is a compound annual growth rate of -9.33%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 20, 2026 | 61.69B | -18.36% |
| Dec 30, 2025 | 75.57B | 2.79% |
| Dec 30, 2024 | 73.52B | 0.08% |
| Dec 28, 2023 | 73.46B | 5.85% |
| Dec 29, 2022 | 69.40B | -30.44% |
| Dec 30, 2021 | 99.78B | 1.96% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BIO-FD&C | 72.78B |
| CTCBIO | 70.05B |
| QuadMedicine | 68.89B |
| AriBioLab | 67.82B |
| EyeGene | 64.46B |
| KoBioLabs | 63.40B |
| ABION | 60.82B |
| Aptamer Sciences | 57.44B |